Aphios Selected by SAIC-Frederick, Inc. (SAI) to Develop Camposomes(TM) in Support of the National Cancer Institute’s Alliance for Nanotechnology in Cancer  
2/1/2011 8:56:47 AM

WOBURN, Mass.--(BUSINESS WIRE)--Aphios® Corporation today announced that it has entered into a subcontract with SAIC-Frederick, a subsidiary of Science Applications International Corporation, to develop phospholipid nanoencapsulated camptothecin, Camposomes™, for the treatment of pancreatic and other cancers, supporting the NCI Alliance for Nanotechnology.